Carrier detection in Duchenne muscular dystrophy: A review of current issues and approaches

作者: Hanns-Dieter Gruemer , Thomas Prior

DOI: 10.1016/0009-8981(87)90227-0

关键词:

摘要: The clinical chemistry laboratory has traditionally played a passive role in the application of technology to diagnostic interpretation. Recent developments offer laboratorian renewed potential enter patient care arena as consultant. Our lack understanding disease processes muscular dystrophies places emphasis on prevention through carrier detection. This review summarizes progress disease, our present genetics that control mode inheritance and analytical approaches detection, including their advantages limitations. advances allow examination genetic material itself instead concentrating phenotypic expression biochemical abnormalities.

参考文章(97)
A. D. Ho, S. Stojakowits, B. Reitter, W. Fiehn, G. Zipperle, W. Hunstein, Ch. Lipinski, Capping of lymphocytes in patients and carriers of duchenne muscular dystrophy Journal of Molecular Medicine. ,vol. 58, pp. 377- 381 ,(1980) , 10.1007/BF01477281
Zatz M, Peres Ca, Frota-Pessoa O, Levy Ja, Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study. Journal de génétique humaine. ,vol. 24, pp. 153- ,(1976)
Francke U, Distèche C, Pagon Ra, de Martinville B, Pearson Pl, Ochs Hd, van Ommen Gj, Hofker Mh, Lindgren, Giacalone J, Minor Xp21 chromosome deletion in a male associated with expression of duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome American Journal of Human Genetics. ,vol. 37, pp. 250- 267 ,(1985)
C.A. Maunder-Sewry, V. Dubowitz, Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy Journal of the Neurological Sciences. ,vol. 49, pp. 305- 324 ,(1981) , 10.1016/0022-510X(81)90087-3
N E Morton, C S Chung, H A Peters, Serum enzymes and genetic carriers in muscular dystrophy. American Journal of Human Genetics. ,vol. 12, pp. 52- 66 ,(1960)
A. LETH, K. WULFF, M. CORFITSEN, J. ELMGREEN, Progressive muscular dystrophy in Denmark. Natural history, prevalence and incidence. Acta Paediatrica. ,vol. 74, pp. 881- 885 ,(1985) , 10.1111/J.1651-2227.1985.TB10052.X
W G Miller, P D Crane, C Cryer, Interlaboratory standardization of enzyme results: the Richmond project. Clinical Chemistry. ,vol. 32, pp. 1525- 1531 ,(1986) , 10.1093/CLINCHEM/32.8.1525
H D Gruemer, W G Miller, V M Chinchilli, R T Leshner, C R Hassler, P A Blasco, W E Nance, B M Goldsmith, Are reference limits for serum creatine kinase valid in detection of the carrier state for Duchenne muscular dystrophy Clinical Chemistry. ,vol. 30, pp. 724- 730 ,(1984) , 10.1093/CLINCHEM/30.5.724
B M Goldsmith, H D Gruemer, R J Hawley, N A Pickard, H L Verrill, W E Nance, G Miller, R G Crawford, The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait. Clinical Chemistry. ,vol. 26, pp. 754- 759 ,(1980) , 10.1093/CLINCHEM/26.6.0754